Gilead Sciences Inc (NASDAQ:GILD)

67.38
Delayed Data
As of May 25
 -0.15 / -0.22%
Today’s Change
63.76
Today|||52-Week Range
89.54
-5.95%
Year-to-Date

Today’s Trading

Previous close67.53
Today’s open67.65
Day’s range67.00 - 67.93
Volume4,864,615
Average volume (3 months)7,980,816
Market cap$87.2B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-64.69%
Earnings growth (this year)-30.28%
Earnings growth (next 5 years)-3.20%
Revenue growth (last year)-13.79%
P/E ratio25.6
Price/Sales3.62
Price/Book4.29

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+0.28+0.16%
BIIBBiogen+1.80+0.63%
ILMNIllumina Inc-4.61-1.70%
----
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateJuly 25, 2018
EPS forecast (this quarter)$1.55
Annual revenue (last year)$26.1B
Annual profit (last year)$4.6B
Net profit margin17.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
CFO, Principal Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts